TIM SmartVap D, Instructions For Use Manual

Page: 16 / 132

2 Safety
16 SmartVap Vaporizer SW 1.n, Instructions for use (en-US)
2.1.9 Device malfunctions during use
A device malfunction during use may result in an underdosing of volatile anaesthetic and
thus pose a risk to the patient.
Keep an alternative means of sedation available in case of such a malfunction.
2.1.10 Monitoring the patient
Overdosing or underdosing of volatile anaesthetic may result in risk to the patient.
Monitor the dosing of the volatile anaesthetic by measuring the dosage-relevant end-
tidal concentration of anaesthesia gas (etVA).
The use of volatile anaesthetics can affect the patient's hemodynamic status and pose a
risk.
Ensure cardiovascular monitoring of the patient.
The simultaneous use of an additional anaesthesia gas could lead to an overdose of vola-
tile anaesthetic and thus pose a risk to the patient.
Do not feed an additional volatile anaesthetic agent such as Sevoflurane or Isoflu-
rane through the anaesthesia workstation connected to the vaporizer.
If laughing gas (N
2
O) is used, you must follow the instructions of the manufacturer of
the volatile anaesthetic regarding possibly required adjustments to the concentration
of the volatile anaesthetic
.
2.1.11 Alarms
If alarm signals are not perceived, this may pose a risk to the patient.
Before each use, check that the visual and acoustic alarm signals function correctly
during the device test.
The user must be within hearing range of the acoustic alarm signal.
Set the alarm volume loud enough to be heard.
Always keep the display and status LEDs unobstructed.